IBO
Impact BioMedical, Inc.
AMEX: IBO · HEALTHCARE · BIOTECHNOLOGY
$0.46
+4.35% today
Updated 2026-09-11
Market cap
$52.83M
P/E ratio
0.56
P/S ratio
1,509.50x
EPS (TTM)
$0.88
Dividend yield
—
52W range
$0 – $1
Volume
0.1M
Impact BioMedical, Inc. (IBO) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$0.46
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 0.56x (capped 25x) · Margin: 2,260.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.